Skip to main content
Premium Trial:

Request an Annual Quote

Presidential Award for Young Princeton Bioinformaticist

Premium

Even the White House is showering praise on Gen G, the rapidly growing ranks of successful young genome scientists.

Mona Singh, 34, was one of 60 recipients of the Presidential Early Career Award for Scientists and Engineers, bestowed by the Office of Science and Technology Policy. The computer scientist who joined Princeton University’s faculty in 1999 has been tackling bioinformatics ever since. “I think I’ll be working on these problems for a long time,” Singh says. The problems she’s trying to crack involve using statistical methods to look for common patterns in protein interactions.

It was her exploration into machine learning that started her down the road to computational biology and finally won her heart. “There are a lot of machine learning and algorithmic questions that come up in computational biology,” Singh says. “Bonnie Berger [at MIT] really exposed me to those kinds of problems.”

Before she knew it, Singh was spending more time in the field. And after a brief stint at the Whitehead Institute, she was hooked.

“I think it does take a while to effectively switch fields. But … it was a great thing to actually get trained in both,” she says. “It was wonderful for me to immerse myself in biology in Peter KiM’s lab at the Whitehead Institute.”

Singh also relishes recruiting new converts to computational molecular biology at Princeton. She has a joint appointment with Princeton’s Lewis-Sigler Institute for Integrative Genomics, where her work is supported in part by a five-year, $550,000 NSF grant.

Winning the award hasn’t changed any of Singh’s plans, though. “I’m really excited. It doesn’t change my scientific mission, but it makes me feel good.”

— Jasmin Chua

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more